OPKO Health Says FDA Accepts Resubmission Of NDA For Its RAYALDEE
April 27, 2016 at 14:10 PM EDT
OPKO Health, Inc. (NYSE: OPK) disclosed that the FDA in the United States accepted its resubmission of the New Drug Application (NDA) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.